Eberhard Kwiatkowski
PharmAdvantageIT

PharmAdvantageIT

Körber Pharma Consulting

Kereon
Why should you attend this event?
CSA is the result of an initiative by the life sciences industry and the FDA to promote a risk-based approach that focuses more strongly on software quality while significantly reducing the documentation burden. Following an initial draft in 2022, the FDA published the final version on 3 February 2026.
Identifying the Intended Use
Determining the Risk-Based Approach
Determining the Appropriate Activities
Additional Considerations for Assurance Activities
Establishing the Appropriate Records
Considerations for Electronic Records Requirements
CSV vs. CSA – Relationship to other Regulations
Assessment – What is Good, Useful, Unsuitable
| ECA-Member*: | € 1090,- |
| Regular Fee*: | € 1290,- |
| EU/GMP Inspectorates*: | € 645,- |
| APIC Member Discount*: | € 1190,- |
(All prices excl. VAT). Important notes on sales tax.
This course is part of the GMP Certification Programme "ECA Certified Computer Validation Manager"
Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org